Cargando…
“Diagnostic and Prognostic Biomarkers of Luminal Breast Cancer: Where are We Now?”
Luminal breast cancers are hormone receptor (estrogen and/or progesterone) positive that are further divided into HER2-negative luminal A and HER2-positive luminal B subtypes. According to currently accepted convention, they represent the most common subtypes of breast cancer, accounting for approxi...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392911/ https://www.ncbi.nlm.nih.gov/pubmed/37533589 http://dx.doi.org/10.2147/BCTT.S340741 |